Varalakshmi Elango, MD

Consultant Microbiologist
Global Antibiotic R&D Partnership
Chennai, Tamil Nadu, India

Disclosure information not submitted.

Presentation(s):

• 646 - Subgroup Analyses of Microbiological Cure Rates by Baseline Zoliflodacin MIC and Susceptibility to Ciprofloxacin in Participants from the Global Zoliflodacin Phase 3 Randomized Controlled Trial

  Wednesday, October 22, 2025
  2:45 PM - 2:57 PM US ET